StonvexLoading…
StonvexStonvexStonvexCore line items from UCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $71.46M | $73.82M | $89.57M | $158.38M |
Operating Income | $-19.19M | $-45.91M | $-62.98M | $5.51M |
Net Income | $-19.85M | $-46.04M | $-63.41M | $5.21M |
EPS (Diluted) | $-0.06 | $-0.16 | $-0.25 | Not available |
Total Assets | $45.93M | $67.13M | $97.25M | $90.10M |
Total Liabilities | $36.64M | $47.03M | $40.86M | $47.65M |
Cash & Equivalents | $14.92M | $7.87M | $21.99M | $37.32M |
Free Cash Flow OCF − CapEx | $3.99M | $-22.52M | $-3.29M | $3.01M |
Shares Outstanding | 312.49M | 285.98M | 259.85M | 232.45M |